{"transactions":[{"id":3143671,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-19T23:05:25.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2021 or January 15, 2021 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2022 or January 15, 2022."}],"balance_after":100000,"derivative":{"exercise_price":0.79,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-20-030704","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120030704/doc4.xml","form_type":"4"}},{"id":3214114,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T22:05:17.000Z","date":"2020-03-09","kind":"grant","acquired":true,"shares":1551724,"price":0.29,"value":449999.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was in connection with a private placement issuance by the Issuer which was approved by the Issuer's board of directors."}],"balance_after":7072264,"source":{"system":"sec-edgar","filing":"0001209191-20-018614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120018614/doc4.xml","form_type":"4"}},{"id":3283078,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-10T23:54:02.000Z","date":"2019-12-31","kind":"sale","acquired":false,"shares":40000,"price":0.28,"value":11200.0,"ownership":{"direct":true},"balance_after":5520540,"source":{"system":"sec-edgar","filing":"0001209191-20-008082","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120008082/doc4.xml","form_type":"4"}},{"id":3283077,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-10T23:54:02.000Z","date":"2020-12-19","kind":"sale","acquired":false,"shares":748880,"price":0.29,"value":217175.2,"ownership":{"direct":true},"balance_after":5560540,"source":{"system":"sec-edgar","filing":"0001209191-20-008082","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120008082/doc4.xml","form_type":"4"}},{"id":3287057,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-06T23:02:41.000Z","date":"2019-10-02","kind":"grant","acquired":true,"shares":862068,"price":0.29,"value":249999.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The previously filed Form 4 report incorrectly stated the Code as P.  The transaction was in connection with a private placement issuance by the Issuer which was approved by the Issuer's board of directors and therefore the transaction should have been reported under the Code A."}],"balance_after":6309420,"source":{"system":"sec-edgar","filing":"0001209191-20-007273","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120007273/doc4a.xml","form_type":"4/A","original_submission_date":"2019-10-03"}},{"id":3399286,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-03T22:30:22.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2021 or January 15, 2021."}],"balance_after":100000,"derivative":{"exercise_price":0.29,"expiration_date":"2029-10-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-19-052412","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119052412/doc4.xml","form_type":"4"}},{"id":3399285,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-03T22:30:22.000Z","date":"2019-10-02","kind":"purchase","acquired":true,"shares":862068,"price":0.29,"value":249999.72,"ownership":{"direct":true},"balance_after":6309420,"source":{"system":"sec-edgar","filing":"0001209191-19-052412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119052412/doc4.xml","form_type":"4"}},{"id":3479310,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-25T21:30:54.000Z","date":"2019-05-09","kind":"purchase","acquired":true,"shares":862068,"price":0.29,"value":249999.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4 Report filed May 13, 2019 stated that the number of shares acquired was 714,285 at a price of $0.35 per share. This amendment reflects an amendment to the price per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The original Form 4 Report filed May 13, 2019 stated that the number of shares acquired was 714,285 at a price of $0.35 per share. This amendment reflects an amendment to the price per share."}],"balance_after":5447352,"source":{"system":"sec-edgar","filing":"0001209191-19-038988","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119038988/doc4a.xml","form_type":"4/A","original_submission_date":"2019-05-13"}},{"id":3530348,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T22:04:44.000Z","date":"2019-05-09","kind":"purchase","acquired":true,"shares":714285,"price":0.35,"value":249999.75,"ownership":{"direct":true},"balance_after":5299569,"source":{"system":"sec-edgar","filing":"0001209191-19-029435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119029435/doc4.xml","form_type":"4"}},{"id":3606848,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-08T01:30:06.000Z","date":"2019-03-05","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2021 or January 15, 2021."}],"balance_after":200000,"derivative":{"exercise_price":0.45,"expiration_date":"2029-03-05","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-19-017903","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119017903/doc4.xml","form_type":"4"}},{"id":3643142,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2019-02-21T22:40:13.000Z","date":"2019-02-19","kind":"other","acquired":false,"shares":213333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.35,"exercise_date":"2014-08-22","expiration_date":"2019-08-22","underlying":"Common Stock","underlying_shares":213333},"source":{"system":"sec-edgar","filing":"0001209191-19-012192","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119012192/doc4.xml","form_type":"4"}},{"id":3643141,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2019-02-21T22:40:13.000Z","date":"2019-02-19","kind":"grant","acquired":true,"shares":213333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions relate to an amendment of the exercise price of an outstanding warrant from $0.75 per share to $0.35 per share of Common Stock, contingent upon the Reporting Person immediately exercising the Warrant. As a result of this amendment, the outstanding warrant was deemed canceled and a replacement warrant was issued for the same number of shares of Common Stock, but with the reduced exercise price.  The outstanding warrant was originally issued on August 2014."}],"balance_after":213333,"derivative":{"exercise_price":0.35,"exercise_date":"2014-08-22","expiration_date":"2019-08-22","underlying":"Common Stock","underlying_shares":213333},"source":{"system":"sec-edgar","filing":"0001209191-19-012192","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119012192/doc4.xml","form_type":"4"}},{"id":3643140,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2019-02-21T22:40:13.000Z","date":"2019-02-19","kind":"disposition_to_issuer","acquired":false,"shares":213333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions relate to an amendment of the exercise price of an outstanding warrant from $0.75 per share to $0.35 per share of Common Stock, contingent upon the Reporting Person immediately exercising the Warrant. As a result of this amendment, the outstanding warrant was deemed canceled and a replacement warrant was issued for the same number of shares of Common Stock, but with the reduced exercise price.  The outstanding warrant was originally issued on August 2014."}],"balance_after":0,"derivative":{"exercise_price":0.75,"exercise_date":"2014-08-22","expiration_date":"2019-08-22","underlying":"Common Stock","underlying_shares":213333},"source":{"system":"sec-edgar","filing":"0001209191-19-012192","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119012192/doc4.xml","form_type":"4"}},{"id":3643139,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-21T22:40:13.000Z","date":"2019-02-19","kind":"other","acquired":true,"shares":213333,"price":0.35,"value":74666.55,"ownership":{"direct":true},"balance_after":4585284,"source":{"system":"sec-edgar","filing":"0001209191-19-012192","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119012192/doc4.xml","form_type":"4"}}]}